Circular RNA circTP63 enhances estrogen receptor-positive breast cancer progression and malignant behaviors through the miR-873-3p/FOXM1 axis

Yibin Deng,Jing Xia,Yue-E Xu,Yue-e Xu
DOI: https://doi.org/10.1097/cad.0000000000001010
2020-10-28
Abstract:Circular RNAs (circRNAs) have been shown to play a functional role in a variety of cancers. However, few studies on circRNAs in estrogen receptor-positive breast cancer have been conducted. Here, we investigated the role of circRNA <em>circTP63</em> in estrogen receptor-positive breast cancer progression and malignant behaviors. First, we observed increased expression of <em>circTP63</em> in MCF7 cells relative to normal human mammary epithelial cell lines, such as DU4475 and MCF-10A, and the changed oncogenicity of MCF7 cells correlated with <em>circTP63</em> overexpression and downregulation. Interestingly, a series of gain- and loss-of-function assays revealed that a higher level of FOXM1 was closely associated with MCF7 malignant behaviors induced by <em>circTP63</em> overexpression. Further investigations showed that <em>circTP63</em> sponged to <em><span class="ej-keyword">miR-873-3p</span></em>, which targeted FOXM1 mRNA and inhibited its expression. Mechanistically, <em>circTP63</em> binds to <em><span class="ej-keyword">miR-873-3p</span></em> and prevents the targeting of FOXM1, thus inducing the progression and malignant behaviors of estrogen receptor-positive breast cancer, such as cell proliferation, cell cycle dysregulation, invasion, migration and even tumor growth. <em>CircTP63</em> might be a potential biomarker or target to treat estrogen receptor-positive breast cancer patients in the future.
oncology,pharmacology & pharmacy
What problem does this paper attempt to address?